Key result
Morbid obesity is linked to adverse hemorheological changes independent of metabolic syndrome.
Why the study?
The association between metabolic syndrome and hemorheological parameters among obese patients qualified for bariatric surgery was not well characterized.
Is metabolic syndrome associated with hemorheological alterations in morbidly obese patients qualified for bariatric surgery?
Cross-Sectional (n=73)
Is metabolic syndrome associated with hemorheological alterations in morbidly obese patients qualified for bariatric surgery?
Morbid obesity itself, rather than the presence of metabolic syndrome, appears to be the primary driver of hemorheological disturbances in patients qualifying for bariatric surgery.
Answers are grounded in this paper and cite their sources.
Morbid obesity may drive hemorheological disturbances more than metabolic syndrome in bariatric candidates; leaves open prognostic relevance and causal impact.
This study presents the association between metabolic syndrome and hemorheological parameters among obese patients qualified for bariatric surgery. We studied 73 morbidly obese patients who were qualified for bariatric surgery. Blood and plasma viscosity measurements were performed using a cone-plate viscometer (Brookfield DV-II). RBC aggregation was measured using the Laser-assisted Optical Rotational Cell Analyser (LORCA). The following parameters for the aggregation process were estimated: aggregation index (AI), amplitude (AMP), aggregation half-time (t1/2), threshold shear rate (γthr), the fast (Tfast) and the slow (Tslow) component. Metabolic syndrome was defined according to the Adult Treatment Panel III and International Diabetes Federation criteria. The obese presented differences in all rheological properties compared to control, regardless of clinical diagnosis of metabolic syndrome, except that whole blood viscosity was higher only in the obese metabolic syndrome group. No differences among the obese with and without metabolic syndrome were observed except in hematocrit. Whole blood viscosity and corrected blood viscosity correlated positively with WHR and BMI. AI, γthr, Tslow correlated positively with BMI, WHR, total cholesterol level and low-density lipoproteins. Negative correlation presented t1/2 with BMI, WHR, fibrinogen, total cholesterol level and low-density lipoproteins. The study showed that morbid obesity is associated with hemorheological disturbances independently of clinical diagnosis of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Wiewióra et al. (2014) conducted a cross-sectional in Morbid obesity and metabolic syndrome (n=73). Morbid obesity and metabolic syndrome vs. Controls and obese patients without metabolic syndrome was evaluated on Hemorheological parameters (blood and plasma viscosity, RBC aggregation). Morbid obesity was associated with hemorheological disturbances compared to controls, independently of the clinical diagnosis of metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: